Personalized follow-up for heart and liver transplant recipients
Part of Cancer, Digestive system clinical trials.
This study looks at data from people who have had a heart or liver transplant to find ways to personalize their follow-up care. By using computer algorithms, blood tests, and quality-of-life surveys, the goal is to improve long-term health and well-being.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You had a heart or liver transplant at least 6 months ago.
- You are currently being followed at the IRCCS Azienda Ospedaliero-Universitaria di Bologna (AOUBO).
- You are able to sign a consent form to participate (for the prospective part). If you had a transplant between 2008 and 2020, your existing medical records will be used.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is creating a database of people with severe liver problems or who have had a liver transplant. The goal is to learn more about these conditions and improve care.
This study looks back at medical records of people who had liver cancer (HCC) and had either a transplant or surgery to remove the tumor. It aims to improve a tool that helps predict how well a patient may do, which could guide future treatment decisions.
This study uses artificial intelligence to look at tumor samples and MRI scans from people with advanced liver cancer to help choose the best treatment. It aims to make treatment more personalized and effective.
This study tests whether an artificial intelligence system can help doctors find and treat liver cancer if it comes back after your first surgery or ablation. It focuses on early detection and providing another curative treatment if a recurrence is found.
This study looks at factors that affect heart health after a liver transplant. It may help doctors better predict and manage heart problems in people with end-stage liver disease who are getting a new liver.
This study is following people who have had a liver, kidney, heart, or lung transplant. It will look for markers in your blood that might help predict how you do in the short and long term after transplant.
Hear when a new Artificial Intelligence (AI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.